ES484187A1 - Procedimiento para la preparacion de una vacuna activa con- tra la enfermedad de newcastle y reduccion en la produccion de huevos causados por virus del tipo adeno - Google Patents

Procedimiento para la preparacion de una vacuna activa con- tra la enfermedad de newcastle y reduccion en la produccion de huevos causados por virus del tipo adeno

Info

Publication number
ES484187A1
ES484187A1 ES484187A ES484187A ES484187A1 ES 484187 A1 ES484187 A1 ES 484187A1 ES 484187 A ES484187 A ES 484187A ES 484187 A ES484187 A ES 484187A ES 484187 A1 ES484187 A1 ES 484187A1
Authority
ES
Spain
Prior art keywords
adeno
newcastle disease
viruses
active against
drop caused
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES484187A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gist Brocades NV
Original Assignee
Gist Brocades NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades NV filed Critical Gist Brocades NV
Publication of ES484187A1 publication Critical patent/ES484187A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/235—Adenoviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10111—Atadenovirus, e.g. ovine adenovirus D
    • C12N2710/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

Procedimiento para la preparación de una vacuna activa contra al enfermedad de Newcastle y reducción en la producción de huevos causada por virus del tipo adeno, inactivada combinada dispuesta para administración, caracterizado porque se inactiva líquido que contiene NDV, se homogeneiza discrecionalmente, y junto con un líquido que contiene ALV previamente inactivado y homogeneizado discrecionalmente, se añade a una fase oleosa que contiene, como componentes esenciales, por lo menos uno de los componentes elegidos del grupo consistente en aceite minerales parafínicos ligeros (calidad FDA), aceites vegetales, tal como compuestos iniónicos tensioactivos derivados de óxido de alquileno y/o alcoholes hexahícricos y/o ácidos grasos naturales superiores (C10 - C20), tales como ésteres y éster-éteres, por lo que se añade discrecionalmente un agente de conservación a la fase acuosa.
ES484187A 1978-09-14 1979-09-14 Procedimiento para la preparacion de una vacuna activa con- tra la enfermedad de newcastle y reduccion en la produccion de huevos causados por virus del tipo adeno Expired ES484187A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL7809364 1978-09-14
NL7903300 1979-04-26

Publications (1)

Publication Number Publication Date
ES484187A1 true ES484187A1 (es) 1980-04-01

Family

ID=26645447

Family Applications (2)

Application Number Title Priority Date Filing Date
ES484187A Expired ES484187A1 (es) 1978-09-14 1979-09-14 Procedimiento para la preparacion de una vacuna activa con- tra la enfermedad de newcastle y reduccion en la produccion de huevos causados por virus del tipo adeno
ES485105A Expired ES485105A1 (es) 1978-09-14 1979-10-17 Procedimiento para la preparacion de un liquido inicial que contiene virus de tipo adeno

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES485105A Expired ES485105A1 (es) 1978-09-14 1979-10-17 Procedimiento para la preparacion de un liquido inicial que contiene virus de tipo adeno

Country Status (10)

Country Link
US (1) US4537768A (es)
EP (1) EP0009277B1 (es)
DE (1) DE2966914D1 (es)
DK (1) DK157732C (es)
ES (2) ES484187A1 (es)
FR (1) FR2435949A1 (es)
GR (1) GR70272B (es)
IE (1) IE48482B1 (es)
LU (1) LU81687A1 (es)
PT (1) PT70156A (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7812359A (nl) * 1978-12-20 1980-06-24 Gist Brocades Nv Vaccins tegen door reo virus veroorzaakte ziektever- schijnselen en werkwijze voor het bereiden van deze vaccins.
SU826584A1 (ru) * 1979-10-29 1982-11-07 Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Вакцина против ньюкаслской болезни птиц,способ ее изготовлени и способ профилактики ньюкаслской болезни птиц
US5084271B1 (en) * 1984-09-11 1997-08-05 Univ Melbourne Vaccine for equine herpesvirus
US4613501A (en) * 1984-12-21 1986-09-23 New York Blood Center, Inc. Inactivation of viruses in labile blood derivatives
ES2060740T3 (es) * 1988-07-18 1994-12-01 Duphar Int Res Vacunas de virus vivos para la enfermedad de newcastle.
FR2706665B1 (fr) * 1993-06-11 1995-09-08 Fis Dispositif pour la fixation d'un boîtier d'affichage électronique.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL292949A (es) *
US3083142A (en) * 1958-02-27 1963-03-26 Glaxo Group Ltd Improved swine erysipelas vaccine
US3060094A (en) * 1959-04-07 1962-10-23 Ray M Dutcher Preparation of virus vaccines
US3149036A (en) * 1961-10-16 1964-09-15 Merck & Co Inc Adjuvant vaccine with aluminum monostearate, mannide monooleate, vegetable oil, and an aqueous phase immunolgical agent
US3399263A (en) * 1965-04-12 1968-08-27 American Cyanamid Co Stable adjuvant emulsion compositions comprising the hydrated reaction products of a methallic cation and a fatty acid
US3678149A (en) * 1970-01-26 1972-07-18 Samuel J Prigal Method of enhancing the action of a medicament
NL7012832A (es) * 1970-08-29 1972-03-02
US3876763A (en) * 1970-12-29 1975-04-08 Shionogi & Co Infectious coryza infectious bronchitis and newcastle disease vaccines and production thereof
US3906092A (en) * 1971-11-26 1975-09-16 Merck & Co Inc Stimulation of antibody response
JPS529727B2 (es) * 1971-12-29 1977-03-18
JPS506714A (es) * 1973-05-31 1975-01-23
US3983228A (en) * 1973-08-28 1976-09-28 Merck & Co., Inc. Water-in-oil adjuvant composition
US4069313A (en) * 1974-11-19 1978-01-17 Merck & Co., Inc. Water-in-oil adjuvant composition
US4073743A (en) * 1975-04-17 1978-02-14 Merck & Co., Inc. Process for preparing an emulsion
JPS529727A (en) * 1975-07-11 1977-01-25 Toyota Motor Corp Carburettor
GB1590448A (en) * 1977-03-04 1981-06-03 Akzo Nv Vaccine and its preparations

Also Published As

Publication number Publication date
DE2966914D1 (en) 1984-05-24
IE791745L (en) 1980-03-14
ES485105A1 (es) 1980-06-16
IE48482B1 (en) 1985-02-06
LU81687A1 (fr) 1981-04-17
DK157732C (da) 1990-07-09
US4537768A (en) 1985-08-27
EP0009277A1 (en) 1980-04-02
FR2435949B1 (es) 1984-05-18
EP0009277B1 (en) 1984-04-18
DK157732B (da) 1990-02-12
PT70156A (en) 1979-10-01
DK383079A (da) 1980-03-15
FR2435949A1 (fr) 1980-04-11
GR70272B (es) 1982-09-03

Similar Documents

Publication Publication Date Title
ES2068249T3 (es) Preparacion de glicerol propoxilado esterificado con calidad de alimentacion a partir de acidos grasos libres.
US5650155A (en) Tocols as adjuvant in vaccine
CA1204055A (en) Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines, process for preventing infectious bronchitis and infectious-bronchitis virus strain
ES2052564T3 (es) Procedimiento para la produccion de acido bishomo-gamma-linolenico y acido eicosapanteonico.
MX9306841A (es) Vacuna a base de ureasa contra la infeccion por helicobacter en mamiferos.
DE3473825D1 (en) Method of preparing adjuvanted live vaccines and adjuvanted live vaccines thus obtained
US3655871A (en) Inactivation of influenza viruses with lower alkyl esters of acetic acid
ES484187A1 (es) Procedimiento para la preparacion de una vacuna activa con- tra la enfermedad de newcastle y reduccion en la produccion de huevos causados por virus del tipo adeno
KR840005347A (ko) 정제된 조류의 전위염 레오바이러스분리법 및 전위염백신의 제조방법
ES8107026A1 (es) Procedimiento para preparar una vacuna inactivada de reo-vi-rus
DE3854857D1 (de) Verhütung und behandlung einer retrovirenkrankheit
US4515777A (en) Vaccines
JPS6244528B2 (es)
EP0343548B1 (de) Antigenlösung ethaltend ein Polyalphaolefin (PAO), Verfahren ihrer Herstellung und die Verwendung von PAO als Adjuvans
JPS5656223A (en) Starch sugar ester
IE58822B1 (en) Biological preparations
GB586918A (en) Improvements relating to cartons for use as flower pots
IL102297A0 (en) Marek's disease vaccine
Traub MULTIPLICATION IN VITRO OF PSEUDORABIES VIRUS IN THE TESTICLE TISSUE OF IMMUNIZED GUINEA PIGS
JPH0571570B2 (es)
GB776644A (en) Preparations for the care of the human hair and scalp
ES2053402A1 (es) Metodo de preparacion de vacunas inactivadas y vacunas vivas adyuvantadas asi como las vacunas obtenidas por dicho metodo.
JPS5665817A (en) Vitamin k injection
GB591198A (en) Improvements in or relating to fish hooks
JPS57126445A (en) Novel methyl ester derived from 2,2-dimethylcyclopropane-1,3-dicarboxylic acid, manufacture and obtained novel intermediate